Company / R&D Expense
PROCEPT BioRobotics Corp R&D Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$71.3M
FY2025
5-year range
$19.0M / $71.3M
FY2021-FY2025
Trend
+14.4%
vs FY2024
Sector context
#68 of 105
Health Care
What the data says
At $71M, PROCEPT BioRobotics Corp's r&d expense ranks #68 of 105 in the Health Care sector. R&D Expense has increased for 5 consecutive years, from $16M in FY2020 to $71M in FY2025.
Based on SEC 10-K filings.
$71M in FY2025 with a 5-year CAGR of +34.4%.
Improved from $48M to $71M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +35.0%
- 5-Year CAGR
- +34.4%
- 10-Year CAGR
- -
Sector benchmark
#68 of 105 in Health CareTop 65% of 105This company $71.3M Sector average $283.8M
▼
-74.9% below sector average
Key checks
Key Insights
- PROCEPT BioRobotics Corp's r&d expense has grown for 5 consecutive years.
- 5-year CAGR of +34.4%, indicating consistent growth.
- In FY2025, r&d expense increased 14.4% year-over-year.
- Ranks #68 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $71.3M | +14.4% |
| FY2024 | $62.3M | +28.6% |
| FY2023 | $48.4M | +67.2% |
| FY2022 | $29.0M | +52.6% |
| FY2021 | $19.0M | +16.7% |
| FY2020 | $16.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026